Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2021-09-16 00:00:00 ET · period of report 2021-09-14 · accession 0001209191-21-056459 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-16 | 2021-09-14 | TVTX | Brinkley Ruth Williams | Dir | A - Grant | $0.00 | +5,250 | 5,250 | New | $0 |
| D | 2021-09-16 | 2021-09-14 | TVTX | Brinkley Ruth Williams | Dir | A - Grant | $0.00 | +15.8K | 15.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-14 | A | A | 5,250 | $0.00 | 5,250 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-09-14 | A | A | 15,750 | $0.00 | 15,750 | D | $23.61 · — to 2031-09-13 | 15,750 Common Stock | (F1) One-third of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 24 equal monthly installments thereafter. |